Ivermectin Medical Valley

Ivermectin, the active ingredient in Ivermectin Medical Valley, is an antiparasitic (macrocyclic lactone) presented as an oral formulation for systemic use. It is employed to treat a range of helminthic and ectoparasitic infections in both adults and children where indicated.

GNH USA supplies Ivermectin Medical Valley as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ivermectin acts on a variety of parasitic infections by targeting the nervous system of the organisms. It is clinically employed for the following conditions: - Onchocerciasis: reduces microfilarial load and helps prevent blindness. - Strongyloidiasis: eliminates intestinal larvae and prevents disseminated disease. - Scabies: eradicates the Sarcoptes mite, relieving itching and skin lesions. - Lymphatic filariasis (in combination therapy): contributes to parasite clearance when used with other agents. - Other intestinal nematode infections: treats infections such as ascariasis and hookworm.

Ivermectin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Nausea: mild to moderate upset stomach. - Diarrhea: loose stools during treatment. - Abdominal pain: cramping or discomfort. - Pruritus: itching, often related to parasite die‑off. - Headache: mild headache during therapy.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction requiring immediate medical attention. - Hepatotoxicity: elevated liver enzymes or liver injury. - Anaphylaxis: acute allergic reaction with breathing difficulty. - Visual disturbances: blurred vision or optic neuritis. - Neurologic toxicity: seizures or altered mental status. - Severe skin rash: extensive rash or exfoliative dermatitis.

Before prescribing Ivermectin, clinicians should consider several safety aspects. - Assess liver function: evaluate hepatic status as metabolism is hepatic. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Monitor neurologic symptoms: watch for dizziness, seizures, or confusion. - Use cautiously in high parasite burden: risk of severe inflammatory response. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Ivermectin may interact with other medicines, requiring attention to potential effects.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase ivermectin plasma levels. - Concurrent neurotoxic agents (e.g., albendazole): heightened risk of neurotoxicity. - Warfarin: possible enhancement of anticoagulant effect.

Moderate Interactions (Monitor Closely): - P‑glycoprotein substrates: may alter drug exposure. - Macrolide antibiotics (e.g., erythromycin): require monitoring for increased levels. - Other antiparasitics: combined use may raise adverse‑event risk.